---
schema_version: "secwatch.filing_event.v1"
accession: "0001826466-22-000028"
form_type: "8-K"
ticker: "NIKA"
cik: "0001145604"
company_name: "NIKA PHARMACEUTICALS, INC"
filed_at: "2022-04-05T23:59:59+00:00"
generated_at: "2026-06-26T09:19:23.543192+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Centennial Growth Equities changes control; Savov buys 87% stake, becomes CEO

## Summary
- Dimitar Slavchev Savov purchased 11,489,000 shares (87%) from Phil E. Ray and other shareholders, triggering change of control on April 1, 2022.
- Phil E. Ray resigned as Director, President, and CEO; A. Terry Ray resigned as Director and Secretary; both effective March 31, 2022, with no disagreements.
- Savov and Clifford Redekop appointed Directors March 31; Savov named President, CEO, CFO; Redekop named Secretary effective April 1, 2022.

## SEC filing metadata
- accession: 0001826466-22-000028
- form_type: 8-K
- ticker: NIKA
- cik: 0001145604
- company_name: NIKA PHARMACEUTICALS, INC
- filed_at: 2022-04-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1145604/000182646622000028/0001826466-22-000028-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1145604/000182646622000028/form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001826466-22-000028
- JSON: https://secwatch.observer/filing/0001826466-22-000028.json
- Plain text: https://secwatch.observer/filing/0001826466-22-000028.txt

## Key facts
- Executive change
  Dimitar Slavchev Savov was appointed as President, Chief Executive Officer, Chief Financial Officer at NIKA PHARMACEUTICALS, INC.
  - Action: appointed
  - Role: President, Chief Executive Officer, Chief Financial Officer
  source text: On April 1, 2022, the board of directors accepted the resignations of Mr. Phil E. Ray and Mrs. A. Terry Ray and appointed Dimitar Slavchev Savov to serve as President, CEO, CFO and Clifford Redekop to serve as Secretary of the Corporation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1145604/000182646622000028/0001826466-22-000028-index.htm
- Executive change
  Dimitar Slavchev Savov was appointed as Director at NIKA PHARMACEUTICALS, INC.
  - Action: appointed
  - Role: Director
  source text: Effective as of March 31, 2022, the board of directors appointed Dimitar Slavchev Savov, and Clifford Redekop to serve as the Registrant’s Directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1145604/000182646622000028/0001826466-22-000028-index.htm
- Executive change
  Clifford Redekop was appointed as Director at NIKA PHARMACEUTICALS, INC.
  - Action: appointed
  - Role: Director
  source text: Effective as of March 31, 2022, the board of directors appointed Dimitar Slavchev Savov, and Clifford Redekop to serve as the Registrant’s Directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1145604/000182646622000028/0001826466-22-000028-index.htm
- Executive change
  Clifford Redekop was appointed as Secretary at NIKA PHARMACEUTICALS, INC.
  - Action: appointed
  - Role: Secretary
  source text: On April 1, 2022, the board of directors accepted the resignations of Mr. Phil E. Ray and Mrs. A. Terry Ray and appointed Dimitar Slavchev Savov to serve as President, CEO, CFO and Clifford Redekop to serve as Secretary of the Corporation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1145604/000182646622000028/0001826466-22-000028-index.htm
- Executive change
  Phil E. Ray resigned as Director, President and Chief Executive Officer at NIKA PHARMACEUTICALS, INC.
  - Action: resigned
  - Role: Director, President and Chief Executive Officer
  source text: On March 31, 2022, Mr. Phil E. Ray resigned his position as a Director, President and Chief Executive Officer of Centennial Growth Equities, Inc. (the “Registrant ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1145604/000182646622000028/0001826466-22-000028-index.htm
- Executive change
  A. Terry Ray resigned as Director and Secretary at NIKA PHARMACEUTICALS, INC.
  - Action: resigned
  - Role: Director and Secretary
  source text: On March 31, 2022, Mrs. A. Terry. Ray resigned his position as a Director and Secretary of Centennial Growth Equities, Inc. (the “Registrant”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1145604/000182646622000028/0001826466-22-000028-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.